User profiles for "author:M Dalakas"
Marinos DalakasNational and Kapodistrian University of Athens Greece And Thomas Jefferson University … Verified email at med.uoa.gr Cited by 56303 |
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing …
Objectives To develop recommendations for the diagnosis, prevention and treatment of
neuropsychiatric systemic lupus erythematosus (NPSLE) manifestations. Methods The …
neuropsychiatric systemic lupus erythematosus (NPSLE) manifestations. Methods The …
Polymyositis and dermatomyositis
MC Dalakas, R Hohlfeld - The Lancet, 2003 - thelancet.com
The inflammatory myopathies, commonly described as idiopathic, are the largest group of
acquired and potentially treatable myopathies. On the basis of unique clinical …
acquired and potentially treatable myopathies. On the basis of unique clinical …
Polymyositis, dermatomyositis, and inclusion-body myositis
MC Dalakas - New England Journal of Medicine, 1991 - Mass Medical Soc
THE polymyositis and dermatomyositis complex encompasses a heterogeneous group of
acquired muscle diseases called inflammatory myopathies because muscle weakness and …
acquired muscle diseases called inflammatory myopathies because muscle weakness and …
[HTML][HTML] A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis
MC Dalakas, I Illa, JM Dambrosia… - … England Journal of …, 1993 - Mass Medical Soc
Background Dermatomyositis is a clinically distinct myopathy characterized by rash and a
complement-mediated microangiopathy that results in the destruction of muscle fibers. In …
complement-mediated microangiopathy that results in the destruction of muscle fibers. In …
[HTML][HTML] Mitochondrial myopathy caused by long-term zidovudine therapy
MC Dalakas, I Illa, GH Pezeshkpour… - … England Journal of …, 1990 - Mass Medical Soc
Both infection with the human immunodeficiency virus type 1 (HIV) and zidovudine (formerly
called azidothymidine [AZT]) cause myopathy. To identify criteria for distinguishing …
called azidothymidine [AZT]) cause myopathy. To identify criteria for distinguishing …
Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy
Long-term zidovudine therapy in patients with human immunodeficiency virus (HIV) infection
can cause a destructive mitochondrial myopathy with histological features of ragged-red …
can cause a destructive mitochondrial myopathy with histological features of ragged-red …
Mitochondrial toxicity of antiviral drugs
W Lewis, MC Dalakas - Nature medicine, 1995 - nature.com
Long-term treatment with antiviral nucleoside analogue drugs, such as AZT, can give rise to
delayed and at times severe mitochondrial toxicity. Although these toxic effects are manifest …
delayed and at times severe mitochondrial toxicity. Although these toxic effects are manifest …
Inflammatory muscle diseases
MC Dalakas - New England Journal of Medicine, 2015 - Mass Medical Soc
Inflammatory Muscle Diseases | NEJM Skip to main content NEJM Group Follow Us Facebook
Twitter Instagram YouTube LinkedIn Prepare to become a physician, build your knowledge …
Twitter Instagram YouTube LinkedIn Prepare to become a physician, build your knowledge …
A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups
LA Love, RL Leff, DD Fraser, IN Targoff, M Dalakas… - Medicine, 1991 - journals.lww.com
A New Approach to the Classification of Idiopathic Inflammat... : Medicine A New Approach to
the Classification of Idiopathic Inflammatory Myopathy: Myositis-Specific Autoantibodies Define …
the Classification of Idiopathic Inflammatory Myopathy: Myositis-Specific Autoantibodies Define …
Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy
…, E Nobile‐Orazio, P Van Doorn, M Dalakas… - Annals of …, 2001 - Wiley Online Library
This multicenter, randomized, double‐blind, crossover trial compared a 6 week course of
oral prednisolone tapering from 60 mg to 10 mg daily with intravenous immunoglobulin …
oral prednisolone tapering from 60 mg to 10 mg daily with intravenous immunoglobulin …